Ajanta Pharma Limited (NSE:AJANTPHARM)
India · Delayed Price · Currency is INR 2,717.10
+18.80 (0.70%)
Jan 28, 2026, 3:00 PM IST
Ajanta Pharma Market Cap
Ajanta Pharma has a market cap or net worth of 336.98 billion as of January 28, 2026. Its market cap has decreased by -10.00% in one year.
Market Cap
336.98B
Enterprise Value
330.04B
Revenue
49.73B
Ranking
n/a
PE Ratio
34.62
Stock Price
2,717.10
Market Cap Chart
Since April 1, 2002, Ajanta Pharma's market cap has increased from 565.80M to 336.98B, an increase of 59,459.43%. That is a compound annual growth rate of 30.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 336.98B | -2.55% |
| Dec 31, 2025 | 345.80B | -5.57% |
| Dec 31, 2024 | 366.20B | 39.58% |
| Dec 29, 2023 | 262.36B | 68.96% |
| Dec 30, 2022 | 155.28B | -19.73% |
| Dec 31, 2021 | 193.46B | 36.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alkem Laboratories | 687.56B |
| Aurobindo Pharma | 657.76B |
| Glenmark Pharmaceuticals | 555.29B |
| Laurus Labs | 548.71B |
| Ipca Laboratories | 371.12B |
| Emcure Pharmaceuticals | 290.20B |
| Gland Pharma | 277.20B |
| Wockhardt | 219.62B |